Evolus (EOLS) Enterprise Value (2018 - 2026)
Evolus (EOLS) posted Enterprise Value of -$49.8 million for Q1 2026, up 7.49% on a QoQ basis from -$53.8 million in Q4 2025, and up 26.66% year-over-year from -$39.3 million in Q1 2025.
Evolus (EOLS) Enterprise Value (2018 - 2026) Analysis & Trends
Evolus' Enterprise Value history runs 9 years deep, the most recent figure standing at -$49.8 million for Q1 2026.
- Quarterly Enterprise Value rose 26.66% year-over-year to -$49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.8 million (up 26.66% YoY) and the FY2025 annual result came in at -$53.8 million, up 38.1% from the prior year.
- Enterprise Value was -$49.8 million for Q1 2026 at Evolus, up from -$53.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$31.5 million in Q1 2023 and bottomed at -$106.7 million in Q1 2022.
- A 5-year average of -$66.2 million and a median of -$62.8 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value tumbled 381.13% — and 2023, when it surged 70.5%.
- Evolus' Enterprise Value stood at -$53.9 million in 2022, then retreated by 16.53% to -$62.8 million in 2023, then tumbled by 38.37% to -$87.0 million in 2024, then soared by 38.1% to -$53.8 million in 2025, then increased by 7.49% to -$49.8 million in 2026.
- Business Quant data shows EOLS's Enterprise Value at -$49.8 million in Q1 2026, -$53.8 million in Q4 2025, and -$43.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -49.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.79 Mn |
| Dec 31, 2025 | -53.83 Mn |
| Sep 30, 2025 | -43.52 Mn |
| Jun 30, 2025 | -61.74 Mn |
| Mar 31, 2025 | -67.89 Mn |
| Dec 31, 2024 | -86.95 Mn |
| Sep 30, 2024 | -85.04 Mn |
| Jun 30, 2024 | -93.67 Mn |
| Mar 31, 2024 | -96.96 Mn |
| Dec 31, 2023 | -62.84 Mn |
| Sep 30, 2023 | -38.69 Mn |
| Jun 30, 2023 | -41.71 Mn |
| Mar 31, 2023 | -31.46 Mn |
| Dec 31, 2022 | -53.92 Mn |
| Sep 30, 2022 | -65.57 Mn |
| Jun 30, 2022 | -84.48 Mn |
| Mar 31, 2022 | -106.67 Mn |
| Dec 31, 2021 | -146.26 Mn |
| Sep 30, 2021 | -107.80 Mn |
| Jun 30, 2021 | -131.74 Mn |